Isocitrate dehydrogenases in physiology and cancer: biochemical and molecular insight

@article{AlKhallaf2017IsocitrateDI,
  title={Isocitrate dehydrogenases in physiology and cancer: biochemical and molecular insight},
  author={Hamoud H. Al-Khallaf},
  journal={Cell & Bioscience},
  year={2017},
  volume={7}
}
  • Hamoud H. Al-Khallaf
  • Published 2017
  • Biology, Medicine
  • Cell & Bioscience
    • Isocitrate dehydrogenases play important roles in cellular metabolism and cancer. This review will discuss how the roles of isoforms 1 and 2 in normal cell and cancer metabolism are distinct from those of isoform 3. It will also explain why, unlike 1 and 2, mutations in isoform 3 in tumor are not likely to be driver ones. A model explaining two important features of isocitrate dehydrogenases 1 and 2 mutations, their dominant negative effect and their mutual exclusivity, will be provided. The… CONTINUE READING
    View on Springer
    cellandbioscience.biomedcentral.com
    35 Citations
    Highly Influencial Citations
    1
    Background Citations
    11
    35 Citations
    Citation Type

    Citation Type

    Isocitrate dehydrogenase variants in cancer — Cellular consequences and therapeutic opportunities
    • 2
    The Landscape of the Anti-Kinase Activity of the IDH1 Inhibitors
    • 1
    • PDF
    NADPH homeostasis in cancer: functions, mechanisms and therapeutic implications
    • 2
    • PDF
    Rescue of TCA Cycle Dysfunction for Cancer Therapy
    • 7
    • PDF
    Wild-Type IDH Enzymes as Actionable Targets for Cancer Therapy
    • 12
    • PDF
    Dysregulation Of Metabolic Enzymes In Tumor And Stromal Cells: Role In Oncogenesis And Therapeutic Opportunities.
    • 3
    Role of tyrosine phosphorylation in modulating cancer cell metabolism.
    IDH-1 deficiency induces growth defects and metabolic alterations in GSPD-1-deficient Caenorhabditis elegans
    • 6
    • PDF
    The impact of AMPK signalling and clinical therapeutics on cancer metabolism
    • Highly Influenced
    Targeting intermediary metabolism enhances the efficacy of BH3 mimetic therapy in hematologic malignancies
    • 6

    References

    SHOWING 1-10 OF 173 REFERENCES
    Isocitrate dehydrogenase mutations in leukemia.
    • 47
    • PDF
    Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis
    • 747
    • PDF
    Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism.
    • 384
    • PDF
    Another small molecule in the oncometabolite mix: L-2-Hydroxyglutarate in kidney cancer
    • 14
    • PDF
    What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer.
    • 379
    • PDF
    Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
    • 1,857
    • PDF
    Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
    • 1,359
    • PDF
    Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
    • 2,731
    • Highly Influential
    • PDF
    (R)-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible
    • 501
    Expanding chemical biology of 2-oxoglutarate oxygenases.
    • 409